Reliability of echocardiographic measurements of myocardial perfusion using commercially produced sonicated serum albumin (Albunex)
Authors:
- Alexander S. BaileyABAlexander S. Bailey
- Alvaro MouraAMAlvaro Moura
- R.DAniel MurrayRMR.DAniel Murray
- Annitta J. MoreheadAMAnnitta J. Morehead
- Jose BrumJBJose Brum
- Gregory PearceGPGregory Pearce
- William J. StewartWSWilliam J. Stewart
- James D. ThomasJTJames D. Thomas
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Myocardial contrast echocardiography has the potential for the assessment of coronary microvascular reserveJACC, 1993
- Myocardial contrast echocardiography for the assessment of coronary blood flow reserve: Validation in humansJACC, 1993
- Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction.Circulation, 1992
- Reproducibility of quantitative myocardial contrast echocardiographyJACC, 1990
- Myocardial perfusion imaging by contrast echocardiography with use of intracoronary sonicated albumin in humansJACC, 1989
- The behavior of sonicated albumin microbubbles within the microcirculation: a basis for their use during myocardial contrast echocardiography.Circulation Research, 1989
- Albunex: A Safe and Effective Commercially Produced Agent for Myocardial Contrast EchocardiographyJournal of the American Society of Echocardiography, 1989
- Myocardial contrast echocardiography in humans. II. Assessment of coronary blood flow reserveJACC, 1988
- Assessment of Myocardial Perfusion with Contrast Enhanced EchocardiographyEchocardiography, 1986
- Value and limitations of computer analysis of digital subtraction angiography in the assessment of coronary flow reserve.Circulation, 1986